Is thrombolysis indicated during cardiopulmonary resuscitation in a patient with ST‑elevation myocardial infarction?

Thrombolysis During CPR in STEMI: Not Recommended as Standard Practice

Thrombolysis during active CPR for STEMI is not recommended based on current guidelines, which list "traumatic or prolonged (>10 min) CPR" as a relative contraindication to fibrinolytic therapy 1. However, this represents a nuanced clinical scenario where guideline recommendations must be balanced against the reality that untreated coronary thrombosis is often the cause of failed resuscitation.

Guideline Position

The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines explicitly classify prolonged CPR (>10 minutes) as a relative contraindication to fibrinolytic therapy 1. This contraindication exists primarily due to bleeding risk from chest compressions causing rib fractures, internal injuries, and potential intrathoracic hemorrhage.

The same guidelines emphasize that coronary angiography should be performed emergently for all cardiac arrest patients with suspected cardiac cause and ST-elevation after return of spontaneous circulation (ROSC) 2. The preferred pathway is: achieve ROSC first → then proceed to emergent coronary angiography and PCI, not thrombolysis during active CPR.

The Critical Distinction: During CPR vs. After ROSC

This is where clinical judgment becomes paramount:

During Active CPR (Ongoing Chest Compressions)

• Not recommended as standard practice
• Only case reports exist showing success 3, 4
• Bleeding risk is theoretical but significant
• Should only be considered in refractory cardiac arrest when:
  • High certainty of STEMI as cause (witnessed arrest with preceding chest pain, ST-elevation documented)
  • Conventional ACLS measures have failed
  • PCI is unavailable or cannot be achieved
  • CPR has been high-quality and <10 minutes duration
  • Family/surrogate consent obtained if possible

After ROSC (Even Brief/Intermittent)

• More reasonable and supported by evidence
• The Berlin EMS study showed 45% survival with excellent neurological recovery when thrombolysis was given during intermittent phases of spontaneous circulation 5
• 96% of survivors in that study received thrombolysis during brief ROSC periods, not during active CPR
• This shifts the risk-benefit calculation significantly

Evidence Quality Assessment

The evidence supporting thrombolysis during CPR consists entirely of:

• Case reports and small case series 3, 6, 7, 4, 8
• One retrospective observational study from Berlin 5
• No randomized controlled trials exist

The Berlin study 5 is the highest quality evidence available, showing:

• 45% overall survival (24/53 patients)
• 100% good neurological recovery in survivors
• 54% of survivors had CPR duration <10 minutes
• Only 4% received thrombolysis during true ongoing CPR (3/53 patients)
• Bleeding complications occurred in only 2 patients (both fatal)

Practical Algorithm for Decision-Making

If patient is in cardiac arrest with confirmed STEMI:

1. Initiate high-quality CPR and ACLS immediately

   • Focus on reversible causes (H's and T's)
   • Coronary thrombosis is likely the culprit

2. Assess PCI availability:

   • If PCI available within 120 minutes → Continue ACLS, transport for emergent PCI after ROSC
   • If PCI unavailable or significantly delayed → Consider thrombolysis pathway below

3. Timing decision for thrombolysis:

   • If ROSC achieved (even briefly): Thrombolysis is reasonable, especially if CPR was <10 minutes 1, 5, 8
   • If no ROSC after 10+ minutes of high-quality CPR: Thrombolysis during ongoing CPR becomes a "last-ditch" rescue therapy consideration only

4. Before giving thrombolysis during active CPR, verify:

   • No absolute contraindications present 1
   • High certainty of STEMI (not PE, not aortic dissection)
   • CPR quality has been excellent (proper compressions, adequate ventilation)
   • Ideally <10 minutes of CPR duration
   • Team consensus and family awareness if feasible

5. If thrombolysis given:

   • Use fibrin-specific agents (tenecteplase or alteplase preferred) 1
   • Continue CPR for at least 20-30 minutes post-administration to allow drug circulation 3, 4
   • Prepare for emergent coronary angiography if ROSC achieved
   • Monitor closely for bleeding complications

Critical Caveats

The CPR duration matters significantly: The evidence shows better outcomes when CPR <10 minutes 5, 8. Beyond this, both neurological injury and bleeding risk increase substantially.

The "relative" nature of the contraindication: Unlike absolute contraindications (prior ICH, active bleeding, suspected dissection), prolonged CPR is listed as relative 1. This means clinical judgment can override it in exceptional circumstances, but the default should be to avoid thrombolysis during active compressions.

Bleeding risk is real but may be overstated: The case series show surprisingly low rates of fatal bleeding 5, 8, though rib fractures are common and correlate with CPR duration 8. The theoretical risk has not materialized as severely as feared in published cases, but publication bias likely exists (successful cases get reported, disasters may not).

Post-ROSC thrombolysis is different: Once ROSC is achieved, even if brief, the risk-benefit calculation changes dramatically. The relative contraindication becomes less relevant, and thrombolysis becomes a reasonable bridge to definitive PCI, especially in resource-limited settings 8.

The Bottom Line for Clinical Practice

In real-world practice: Focus on achieving ROSC first through excellent ACLS, then give thrombolysis if PCI is unavailable. Thrombolysis during ongoing CPR should be reserved for truly refractory arrests with high certainty of STEMI when all other options are exhausted and CPR duration is still <10-15 minutes. The guideline contraindication exists for good reason, but it is relative, not absolute, allowing for rare exceptions in desperate circumstances.